Last Updated: May 3, 2026

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate patents expire, and what generic alternatives are available?

Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate is a drug marketed by Alkem Labs Ltd, Annora Pharma, Bionpharma, Novel Labs Inc, Pai Holdings, Strides Pharma Intl, and Taro. and is included in seven NDAs.

The generic ingredient in SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE?
  • What are the global sales for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE?
  • What is Average Wholesale Price for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE?
Summary for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
US Patents:0
Applicants:7
NDAs:7

US Patents and Regulatory Information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 213924-001 Dec 29, 2023 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Taro SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 206431-001 Mar 19, 2024 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novel Labs Inc SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 202511-001 Feb 23, 2017 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Annora Pharma SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 212903-001 Oct 18, 2024 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE Market Analysis and Financial Projection

Last updated: February 3, 2026

Investment Scenario and Fundamentals Analysis for Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate

Market Overview

Sulfates such as sodium sulfate, potassium sulfate, and magnesium sulfate serve in diverse applications, including manufacturing, agriculture, pharmaceuticals, and consumer products. The global market for these compounds shows variability based on industrial demand, technological developments, and regulatory environments.

Sodium Sulfate

Market Size and Trends

  • Valued at approximately $1.2 billion in 2022, with a compound annual growth rate (CAGR) of around 3% projected through 2028 (Source: MarketsandMarkets).
  • Predominant use in the pulp and paper industry accounts for roughly 45% of demand.
  • Growing production of detergents increases its use in cleaning products.

Key Drivers

  • Expansion of pulp and paper manufacturing in Asia, especially China and India.
  • Environmental regulations promoting the use of sodium sulfate over less eco-friendly alternatives.

Investment Considerations

  • Major producing regions include the US, China, and Germany.
  • Market consolidation trends may influence supply stability.
  • Price volatility is linked to fluctuations in energy costs and raw material supply.

Potassium Sulfate

Market Size and Trends

  • Estimated at approximately $880 million in 2022, with a CAGR of about 4% until 2028.
  • The largest application is as a fertilizer, representing roughly 70% of global consumption.
  • Demand driven by increasing global agricultural productivity and shift toward specialty fertilizers.

Key Drivers

  • Growing global population and food demand heighten fertilizer consumption.
  • Preference for potassium sulfate over potassium chloride due to salt-sensitive crops.

Investment Considerations

  • Major supply regions include Canada, Israel, and Germany.
  • The purity and efficient delivery of potassium sulfate are critical for high-value crops.
  • Market expansion potential in emerging markets; however, price sensitivity remains.

Magnesium Sulfate

Market Size and Trends

  • Valued at approximately $920 million in 2022, with a CAGR of around 4.5% expected through 2028.
  • Uses primarily in pharmaceuticals (e.g., as a magnesium supplement), agriculture, and industrial applications.

Key Drivers

  • Rising health awareness fosters demand for medicinal magnesium sulfate.
  • Increased use in agriculture as a fertilizer additive.

Investment Considerations

  • Key production centers include China, the US, and Chile.
  • Price pressures stem from raw material costs and substitute products.
  • Regulatory approvals for pharmaceutical applications can impact market entry and growth.

Competitive Landscape

  • Industry players include Clarkson Chemicals, Innophos, and QuĂ­mica Amparo.
  • A trend towards integrated supply chains could influence margins.
  • R&D efforts focus on improving purity and cost efficiency.

Regulatory Environment

  • Regulations on environmental emissions impact production processes, especially for sodium sulfate.
  • Agricultural use of potassium sulfate and magnesium sulfate faces crop-specific residue standards.
  • Pharmaceutical applications require adherence to strict quality standards and approvals.

Investment Risks

  • Raw material price fluctuations.
  • Geopolitical uncertainties affecting supply chains.
  • Regulatory changes impacting production or application standards.
  • Market saturation in mature regions.

Strategic Opportunities

  • Expansion into emerging markets with rising infrastructure investments.
  • Development of high-purity grades for pharmaceutical use.
  • Innovation in environmentally sustainable production processes.

Key Takeaways

  • The sulfate markets exhibit steady growth, primarily driven by industrial and agricultural demand.
  • Regional dynamics influence supply, pricing, and market entry barriers.
  • Product purity and compliance standards are crucial for pharmaceutical applications.
  • Raw material costs and raw material supply stability affect profitability.
  • Emerging markets and sustainable production practices present growth prospects.

Frequently Asked Questions

  1. What are the main end-use industries for sulfate compounds?

    • Pulp and paper, fertilizers, detergents, pharmaceuticals, and industrial applications.
  2. How does environmental regulation influence sulfate production?

    • Stricter emissions standards can increase production costs and promote greener manufacturing methods.
  3. What are the critical factors for investing in sulfate markets?

    • Market demand, raw material availability, regulatory environment, and regional market growth potential.
  4. Can sulfate compounds serve as sustainable or eco-friendly alternatives?

    • They can, especially when produced via environmentally friendly processes, but market adoption depends on regulatory and industry standards.
  5. What are the challenges faced by new entrants in sulfate markets?

    • Capital-intensive manufacturing, strict regulatory requirements, and established competitive landscapes.

References

[1] MarketsandMarkets. Global Sulfate Market Report, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.